Intriguingly, data analysis revealed significant upregulation of PAX3 in conjunctival melanoma of poor (7.8 ± 2.3-fold, p = 0.01) and good prognosis (18.7 ± 5.5-fold, p = 0.01) compared to healthy conjunctival tissue (Fig. 5A). The gene discussed is PAX3; the disease is malignant conjunctival melanoma.